1.tif

NanoCarry

Delivery straight to the brain

NanoCarry offers a unique theranostic approach of a nanoparticle-based platform that can efficiently overcome the restrictive mechanism of the Blood-Brain-Barrier (BBB), and deliver bio-therapeutics into the brain. Our commitment to alleviate the suffering of patients with neurological disorders,  remains the key driving force behind our Biotechnology Startup. Our team of professionals is here to inspire you with their unique ideas and abilities.

 

About Us

We’re a young and talented group of researchers, entrepreneurs and engineers offering an innovative solution that will provide a better future for those who suffer from neurological disorders. Our innovative targeted delivery solution for crossing the blood-brain-barrier (BBB) can be adapted to any need.


2.tif
 
vessels_pic_edited.jpg

Our Innovative Technology

NanoCarry aims to alleviate the suffering of patients with neurological disorders, by combining known disease targets and compounds together with an established drug delivery technology for safe targeting. Our nanoparticle-based platform  allows precise targeting of prominent molecular pathways, cells, and tissue types involved in the disease. NanoCarry's hybrid nanoparticles are based on an innovative, patent-protected drug delivery and imaging technique. This versatile nanoplatform technology can be applied to a pipeline of products, with the potential for a transformative impact on the treatment of a broad spectrum of neurological conditions, such as Alzheimer's, Parkinson's and ALS, as well as brain cancer and rare genetic diseases.

 

The NanoCarry Team

Picture1.jpg
Picture2.jpg
Picture3.jpg

Revital Mandil Levin; PhD; MBA

Co-Founder & CEO

Over 15 years experience in business and corporate development in small and mid size biotech and pharmaceutical companies


Ex. VP Corp Dev NeuroDerm (Acq. By MTPC at $1.1B); Ex. CBDO CollPlant (NASDQ: CLGN), Ex. VP Corp. Dev Anima Biotech (Private), VP Bus. Dev HealOr (Private)

Oshra Betzer, PhD

Co-Founder & COO

Bar Ilan post-doctoral fellow in Nano-Bioengineering; PhD in Bioengineering & Neuroscience.
Experience in managing positions in the high-tech industry.

Prof. Rachela Popovtzer

Co-Founder & CSO

Professor and Vice-Dean, Faculty of Engineering, Bar Ilan University.
Expert in nanomedicine, and development of 'smart' nanoprobes for theranostic applications.

 

Get in Touch

UnBox, Bar Ilan Universty, Ramat Gan

052-8308866

 
  • Facebook
  • Twitter
  • LinkedIn

©2019 by TwistGenes. Proudly created with Wix.com